Ventas, Inc. (NYSE:VTR) Stock Has Average Price Target of $99.11 According to Analysts

Ventas, Inc. (NYSE:VTR) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $99.39.

A number of research firms have recently weighed in on VTR. BMO Capital Markets upped their target price on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. Evercore set a $100.00 price objective on shares of Ventas in a research note on Monday. Royal Bank Of Canada boosted their price objective on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Citigroup raised their target price on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 price target on shares of Ventas in a research note on Tuesday, June 16th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Dynamic Wealth Strategies LLC bought a new position in shares of Ventas in the first quarter worth about $25,000. Silvant Capital Management LLC acquired a new position in Ventas during the 2nd quarter worth approximately $28,000. Meeder Asset Management Inc. acquired a new position in Ventas during the 2nd quarter worth approximately $30,000. Reflection Asset Management bought a new position in Ventas in the 4th quarter valued at approximately $34,000. Finally, Manchester Capital Management LLC lifted its stake in shares of Ventas by 60.5% in the 4th quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock valued at $38,000 after acquiring an additional 185 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Price Performance

NYSE:VTR opened at $86.64 on Friday. Ventas has a 52 week low of $66.93 and a 52 week high of $101.60. The firm has a market cap of $44.44 billion, a price-to-earnings ratio of 160.44, a P/E/G ratio of 3.39 and a beta of 0.70. The firm’s 50-day simple moving average is $91.78 and its 200 day simple moving average is $88.05. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44.

Ventas (NYSE:VTR) last announced its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the business posted $0.87 EPS. The business’s revenue was up 21.7% compared to the same quarter last year. As a group, sell-side analysts predict that Ventas will post 3.89 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Wednesday, September 30th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.08 annualized dividend and a yield of 2.4%. Ventas’s dividend payout ratio (DPR) is 385.19%.

Ventas Company Profile

Ventas, Inc is a real estate investment trust (REIT) that owns and manages a diversified portfolio of healthcare and senior living properties. Its real estate platform includes senior housing communities, medical office buildings, life science and innovation centers, and other healthcare-related facilities.

The company generally leases or operates its properties through relationships with healthcare providers, senior living operators, universities, and research institutions. Its properties support services such as independent and assisted living, skilled nursing, outpatient care, physician practices, medical research, and biotechnology development.

Ventas serves major healthcare and life science markets in the United States and Canada.